Functional status-Class II: Mildly disabled Posts on Medivizor
Navigation Menu

Functional status-Class II: Mildly disabled Posts on Medivizor

Achieving stable low disease activity with adalimumab plus methotrexate

Posted by on Apr 12, 2014 in Rheumatoid Arthritis | 0 comments

In a nutshell This trial compared the efficacy of 2 treatment regimens: methotrexate (MTX) monotherapy versus dual therapy of MTX plus biological drug in patients with early rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is an autoimmune disease that occurs when the immune system mistakenly attacks the body’s own tissues, in...

Read More